ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,338Medicare Part D Prescriptions Filled, Including Refills

Rank: 233 out of 676

$534K Total Retail Price of All Prescriptions

Rank: 202 out of 676

439 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

22% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 7,108 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
ZOLPIDEM TARTRATE 328 217 1 21
FUROSEMIDE 314 256 2 4
OMEPRAZOLE 296 214 3 2
HYDROCODONE-ACETAMINOPHEN 287 187 S3 4 1
LEVOTHYROXINE SODIUM 277 259 5 7
SIMVASTATIN 276 238 6 6
LISINOPRIL 223 168 7 5
POTASSIUM CHLORIDE 214 172 8 9
DONEPEZIL HCL 198 184 9 24
HYDROCHLOROTHIAZIDE 191 162 10 12
METFORMIN HCL 168 111 11 8
AMLODIPINE BESYLATE 166 138 12 3
PAROXETINE HCL 165 125 13 65
CARVEDILOL 160 106 14 15
NAMENDA 134 122 15 35
NEXIUM 123 110 16 23
WARFARIN SODIUM 123 109 16 18
ROPINIROLE HCL 118 95 18 85
CIPROFLOXACIN HCL 116 88 19 45
FLUTICASONE PROPIONATE 114 86 20 49
PRAVASTATIN SODIUM 106 65 21 11
PREDNISONE 106 79 21 53
GABAPENTIN 104 64 23 10
MELOXICAM 101 71 24 13
ATENOLOL 92 91 25 25
CITALOPRAM HBR 87 76 26 17
LANTUS 82 52 27 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 52 28 16
NASONEX 80 54 29 243
ATORVASTATIN CALCIUM 77 56 30 20
TRAZODONE HCL 76 54 31 36
BUSPIRONE HCL 76 66 31 113
CLOPIDOGREL 74 52 33 28
ISOSORBIDE MONONITRATE ER 67 64 34 54
ESCITALOPRAM OXALATE 66 61 35 73
MEGESTROL ACETATE 65 50 R 36 111
PANTOPRAZOLE SODIUM 65 42 36 42
CYMBALTA 64 40 38 47
PLAVIX 63 44 39 40
COMBIVENT 63 47 39 174
ALLOPURINOL 60 57 41 31
HALOPERIDOL 58 46 42 158
DIGOXIN 54 54 43 52
JANTOVEN 53 31 44 156
TRAMADOL HCL 51 36 45 19
METFORMIN HCL ER 50 46 46 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.